BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 19244167)

  • 1. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting.
    Ramsoekh D; van Leerdam ME; Wagner A; Kuipers EJ; Steyerberg EW
    J Med Genet; 2009 Nov; 46(11):745-51. PubMed ID: 19541685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Vasen HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
    Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics.
    Orta L; Klimstra DS; Qin J; Mecca P; Tang LH; Busam KJ; Shia J
    Am J Surg Pathol; 2009 Jun; 33(6):934-44. PubMed ID: 19342947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of Muir-Torre syndrome among Lynch syndrome families.
    South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
    J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Lynch syndrome predictive models in a multi-center US referral population.
    Khan O; Blanco A; Conrad P; Gulden C; Moss TZ; Olopade OI; Kupfer SS; Terdiman J
    Am J Gastroenterol; 2011 Oct; 106(10):1822-7; quiz 1828. PubMed ID: 21747416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer.
    Monzon JG; Cremin C; Armstrong L; Nuk J; Young S; Horsman DE; Garbutt K; Bajdik CD; Gill S
    Int J Cancer; 2010 Feb; 126(4):930-9. PubMed ID: 19653273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
    Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
    Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.
    Kastrinos F; Ojha RP; Leenen C; Alvero C; Mercado RC; Balmaña J; Valenzuela I; Balaguer F; Green R; Lindor NM; Thibodeau SN; Newcomb P; Win AK; Jenkins M; Buchanan DD; Bertario L; Sala P; Hampel H; Syngal S; Steyerberg EW;
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
    Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
    Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
    Barrow E; Robinson L; Alduaij W; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2009 Feb; 75(2):141-9. PubMed ID: 19215248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
    Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
    Stoffel EM
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree.
    Ponz de Leon M; Benatti P; Percesepe A; Rossi G; Viel A; Santarosa M; Pedroni M; Roncucci L
    Ital J Gastroenterol Hepatol; 1999; 31(6):476-80. PubMed ID: 10575566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment.
    Jensen LH; Dysager L; Lindebjerg J; Kølvrå S; Byriel L; Crüger DG
    Eur J Cancer; 2010 Jul; 46(10):1823-8. PubMed ID: 20417091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.